相册


基本信息 The basic information
姓名: 李智美

学院: 医学研究院


学历: 博士研究生毕业

学位: 医学博士


职称:

职务:


学科:


邮箱: li_zhimei@nwpu.edu.cn




教育经历 Education Experience
2015/09-2020/06：华中科技大学，同济医学院药学院，药理学，博士
2011/09-2015/06：郑州大学，药学院，药学，学士



工作经历 Work Experience
2020/09-至今：西北工业大学，医学研究院，博士后




科学研究 Scientific Research
主要从事：肿瘤治疗的新靶点发现及抗肿瘤药物的开发。



学术成果 Academic Achievements
1) Zhimei Li, Lixia Chen^*, Hua Li^*. Voltage-Gated Sodium Channels and Blockers: An Overview and Where Will They Go?. Current Medical Science, 2019. 39(6): p. 863-873.
2)Zhimei Li, Yiyuan Zhang, Lixia Chen^*, Hua Li^*. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. Food & Function, 2018. 9(5): p. 3018-3027.
3) Yiwen Zhang^#, Zhimei Li^#, Qiuxia Min^#, Abulizi Palida^#, Yiyuan Zhang, Ruotian Tang^*, Lixia Chen^*, Hua Li^*. 8-Chrysoeriol, as a potential BCL-2 inhibitor triggers apoptosis of SW1990 pancreatic cancer cells. Bioorganic Chemistry, 2018. 77: p. 478-484.
4) Wei Li^#, Mengzhu Zheng^#, Shuangping Wu^#, Suyu Gao, Mei Yang, Zhimei Li, Qiuxia Min, Weiguang Sun, Lixia Chen^*, Guangya Xiang^*, Hua Li^*. Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2. Journal of Experimental & Clinical Cancer Research, 2017. 36(1): p. 1-12.
5) Qiuxia Min, Xinpei Cai, Weiguang Sun, Fei gao, Zhimei Li, Qian Zhang, Luo-Sheng Wan, Hua Li^*, Jiachun Chen^*. Identification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening. Scientific Reports, 2017. 7: p. 1-9.





English Version